Abstract
The majority of lipids in the brain are located in the bilayer membranes. These lipids are not visible by magnetic resonance spectroscopy since they have restricted mobility. Only mobile lipids, such as cholesterol esters or triglycerides in neutral lipid droplets, have enough rotational freedom to generate a signal on spectroscopy. These signals are detected as peaks at 1.3 ppm, originating from the methylene groups in the fatty acid chain, and 0.9 ppm, originating from the distal methyl group. We review the literature on the different genetic conditions that have been found to show lipid peaks on brain spectroscopy and report the first patient with carnitine palmitoyltransferase 2 deficiency shown to have such lipid peaks, thus indicating brain fat accumulation.
Competing interests: None declared
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alkan A, Kutlu R, Yakinci C et al (2003) Delayed myelination in a rhizomelic chondrodysplasia punctata case: MR spectroscopy findings. Magn Reson Imaging 21:77–80
Allen IV, Swallow M, Nevin NC, McCormick D (1978) Clinicopathological study of Refsum’s disease with particular reference to fatal complications. J Neurol Neurosurg Psychiatry 41:323–332
Bruhn H, Kruse B, Korenke GC et al (1992) Proton NMR spectroscopy of cerebral metabolic alterations in infantile peroxisomal disorders. J Comput Assist Tomogr 16:335–344
Caruso PA, Poussaint TY, Tzika AA et al (2004) MRI and 1H MRS findings in Smith–Lemli–Opitz syndrome. Neuroradiology 46:3–14
Confort-Gouny S, Vion-Dury J, Chabrol B et al (1995) Localised proton magnetic resonance spectroscopy in X-linked adrenoleukodystrophy. Neuroradiology 37:568–575
Delorme S, Weber M-A (2006) Applications of MRS in the evaluation of focal malignant brain lesions. Cancer Imaging 6:95–99
Deltetto N, Maxit C, Marchione D et al (2012) Long chain 3-hydroxyacyl-coA dehydrogenase deficiency, association with HELLP and magnetic resonance spectroscopy findings. Arch Argent Pediatr 110:e63–e66
Elpeleg ON, Hammerman C, Saada A et al (2001) Antenatal presentation of carnitine palmitoyltransferase II deficiency. Am J Med Genet 102:183–187
Embiruçu EK, Otaduy MCG, Taneja AK et al (2010) MR spectroscopy detects lipid peaks in cerebrotendinous xanthomatosis. AJNR Am J Neuroradiol 31:1347–1349
Fearing MK, Israel EJ, Sahai I et al (2011) Case records of the Massachusetts General Hospital. Case 12-2011. A 9-month-old boy with acute liver failure. N Engl J Med 364:1545–1556
Groenendaal F, Bianchi MC, Battini R et al (2001) Proton magnetic resonance spectroscopy (1H-MRS) of the cerebrum in two young infants with Zellweger syndrome. Neuropediatrics 32:23–27
Huigen MCDG, van der Graaf M, Morava E et al (2015) Cerebral lipid accumulation in Chanarin–Dorfman syndrome. Mol Genet Metab 114:51–54
Isackson PJ, Bennett MJ, Lichter-Konecki U et al (2008) CPT2 gene mutations resulting in lethal neonatal or severe infantile carnitine palmitoyltransferase II deficiency. Mol Genet Metab 94:422–427
Kimura T, Sako K, Tanaka K et al (2004) Evaluation of the response of metastatic brain tumors to stereotactic radiosurgery by proton magnetic resonance spectroscopy, 201TlCl single-photon emission computerized tomography, and gadolinium-enhanced magnetic resonance imaging. J Neurosurg 100:835–841
Kingsley PB, Shah TC, Woldenberg R (2006) Identification of diffuse and focal brain lesions by clinical magnetic resonance spectroscopy. NMR Biomed 19:435–462
Mano T, Ono J, Kaminaga T et al (1999) Proton MR spectroscopy of Sjögren–Larsson’s syndrome. AJNR Am J Neuroradiol 20:1671–1673
Meir K, Fellig Y, Meiner V et al (2009) Severe infantile carnitine palmitoyltransferase II deficiency in 19-week fetal sibs. Pediatr Dev Pathol 12:481–486
Miyanomae Y, Ochi M, Yoshioka H et al (1995) Cerebral MRI and spectroscopy in Sjögren–Larsson syndrome: case report. Neuroradiology 37:225–228
Nakayama M, Távora DGF, Alvim TCL et al (2006) MRI and 1H-MRS findings of three patients with Sjögren–Larsson syndrome. Arq Neuropsiquiatr 64:398–401
Near J (2013) Spectral quantification and pitfalls in interpreting magnetic resonance spectroscopic data: what to look out for. In: Stagg C, Rothman DL (eds) Magnetic resonance spectroscopy: tools for neuroscience research and emerging clinical applications. San Diego: Academic Press, 49–67
North KN, Hoppel CL, De Girolami U et al (1995) Lethal neonatal deficiency of carnitine palmitoyltransferase II associated with dysgenesis of the brain and kidneys. J Pediatr 127:414–420
Oz G, Tkác I, Charnas LR et al (2005) Assessment of adrenoleukodystrophy lesions by high field MRS in non-sedated pediatric patients. Neurology 64:434–441
Pierce MR, Pridjian G, Morrison S, Pickoff AS (1999) Fatal carnitine palmitoyltransferase II deficiency in a newborn: new phenotypic features. Clin Pediatr (Phila) 38:13–20
Razek AAKA, Abdalla A, Gaber NA et al (2013) Proton MR Spectroscopy of the brain in children with neuronopathic Gaucher’s disease. Eur Radiol 23:3005–3011
Roomets E, Lundbom N, Pihko H et al (2006) Lipids detected by brain MRS during coma caused by carnitine palmitoyltransferase 1 deficiency. Neurology 67:1516–1517
Rossi A, Biancheri R, Zara F et al (2008) Hypomyelination and congenital cataract: neuroimaging features of a novel inherited white matter disorder. AJNR Am J Neuroradiol 29:301–305
Schuurs-Hoeijmakers JHM, Geraghty MT, Kamsteeg E-J et al (2012) Mutations in DDHD2, encoding an intracellular phospholipase A(1), cause a recessive form of complex hereditary spastic paraplegia. Am J Hum Genet 91:1073–1081
Sylvain M, Arnold DL, Scriver CR et al (1994) Magnetic resonance spectroscopy in Niemann–Pick disease type C: correlation with diagnosis and clinical response to cholestyramine and lovastatin. Pediatr Neurol 10:228–232
van Domburg PH, Willemsen MA, Rotteveel JJ et al (1999) Sjögren–Larsson syndrome: clinical and MRI/MRS findings in FALDH-deficient patients. Neurology 52:1345–1352
Viola A, Confort-Gouny S, Ranjeva J-P et al (2002) MR imaging and MR spectroscopy in rhizomelic chondrodysplasia punctata. AJNR Am J Neuroradiol 23:480–483
Willemsen MAAP, Van Der Graaf M, Van Der Knaap MS et al (2004) MR imaging and proton MR spectroscopic studies in Sjögren-Larsson syndrome: characterization of the leukoencephalopathy. AJNR Am J Neuroradiol 25:649–657
Wolinsky JS, Narayana PA, Fenstermacher MJ (1990) Proton magnetic resonance spectroscopy in multiple sclerosis. Neurology 40:1764–1769
Xu D, Vigneron D (2010) Magnetic resonance spectroscopy imaging of the newborn brain–a technical review. Semin Perinatol 34:20–27
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: Jean-Marie Saudubray
Appendices
Synopsis
Patients with long-chain fatty acid β-oxidation disorders in acute crisis can present with cerebral fat accumulation that is detectable by MR spectroscopy.
Compliance with Ethics Guidelines
Conflicts of Interest
Carlos R. Ferreira, Molly H. Silber, Taeun Chang, Jonathan G. Murnick, and Brian Kirmse declare that they have no conflict of interest.
Details of the Contributions of Individual Authors
-
Writing and preparation of the manuscript: CRF, MHS, and JGM
-
Clinical management and investigation of the patient: TC and BK
-
Detailed review of the patient’s brain imaging: JGM
-
Critical review of the manuscript: All authors
Rights and permissions
Copyright information
© 2015 SSIEM and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ferreira, C.R., Silber, M.H., Chang, T., Murnick, J.G., Kirmse, B. (2015). Cerebral Lipid Accumulation Detected by MRS in a Child with Carnitine Palmitoyltransferase 2 Deficiency: A Case Report and Review of the Literature on Genetic Etiologies of Lipid Peaks on MRS. In: Morava, E., Baumgartner, M., Patterson, M., Rahman, S., Zschocke, J., Peters, V. (eds) JIMD Reports, Volume 28. JIMD Reports, vol 28. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2015_506
Download citation
DOI: https://doi.org/10.1007/8904_2015_506
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-52846-4
Online ISBN: 978-3-662-52847-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)